Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BBT-176
i
Other names:
BBT-176
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(5)
News
Trials
Company:
Bridge Biotherap
Drug class:
EGFR inhibitor, Tyrosine kinase inhibitor
Related drugs:
‹
cetuximab (347)
osimertinib (301)
erlotinib (235)
afatinib (227)
gefitinib (194)
panitumumab (123)
lapatinib (107)
neratinib (102)
pyrotinib (79)
brigatinib (50)
icotinib (45)
aumolertinib (39)
amivantamab-vmjw (25)
firmonertinib (14)
mobocertinib (12)
lazertinib (12)
BGB-283 (12)
tarloxotinib bromide (7)
WZ4002 (7)
CH7233163 (6)
H002 (6)
nimotuzumab (6)
BLU-945 (6)
ASLAN001 (6)
CL-387785 (5)
GB263T (5)
rociletinib (5)
BDTX-189 (5)
AEE788 (4)
BI-4020 (4)
tomuzotuximab (4)
JIN-A02 (4)
MET306 (4)
EGF816 (4)
BDTX-1535 (4)
AFM24 (3)
BLU-701 (3)
GC-1118A (3)
necitumumab (3)
befotertinib (3)
sunvozertinib (3)
zorifertinib (3)
BCA101 (3)
S95026 (3)
ASP8273 (3)
MCLA-129 (3)
SZMD4 (3)
ACE2016 (2)
BI-732 (2)
BLU-451 (2)
Bay846 (2)
ERAS-801 (2)
OBX02-011 (2)
olmutinib (2)
QL1203 (2)
CLN-081 (2)
14aj (1)
αEGFR (1)
ABP 494 (cetuximab biosimilar) (1)
APL-103 (1)
BPI-15086 (1)
BPI-361175 (1)
Compound 6a (1)
abivertinib (1)
sevabertinib (1)
KKI04 (1)
PH001 (1)
rilertinib (1)
TAS3351 (1)
TRX-221 (1)
WSD0922 (1)
JMT101 (1)
RT1978 (1)
HMPL-813 (1)
SI-B001 (1)
ASK120067 (1)
HLX07 (1)
Hemay022 (1)
KD019 (1)
ABT-101 (0)
AC480 (0)
AG1478 (0)
BBT-207 (0)
BC3448 (0)
BMS690514 (0)
BNA035 (0)
CM93 (0)
CUDC-101 (0)
EGF-PTI (0)
DF9001 (0)
EGFR (0)
STI-001 (cetuximab biosimilar) (0)
FHND9041 (0)
HS-10375 (0)
antroquinonol (0)
zalutumumab (0)
IAE0972 (0)
IBI-334 (0)
JANX008 (0)
JNJ-26483327 (0)
JS111 (0)
asandeutertinib (0)
MM-151 (0)
MP412 (0)
MTX-211 (0)
PF-08046052 (0)
PM1080 (0)
QLH11811 (0)
rindopepimut (0)
SR13668 (0)
SYN004 (0)
Sym013 (0)
TAK-186 (0)
TAK-285 (0)
TAS-121 (0)
TAVO412 (0)
TQ-B3456 (0)
TQB3804 (0)
U3-1565 (0)
Undisclosed EGFR inhibitor (0)
XZP-5809 (0)
simotinib (0)
ZN-e4 (0)
AST1306 (0)
SY101 (0)
Ami-LC (0)
PLB1004 (0)
EMB-01 (0)
cetuximab biosimilar (0)
cipatinib (0)
ABT-806 (0)
MEHD7945A (0)
RO5083945 (0)
TL007 (0)
EMD 72000 (0)
PF-06747775 (0)
JNJ-64041757 (0)
KBP-5209 (0)
SKLB-1028 (0)
AZD8931 (0)
PD173074 (10)
AG-1296 (1)
vorolanib (1)
KC1036 (1)
quercetin (0)
Tyrosine Kinase inhibitors (0)
SU5416 (0)
XL092 (0)
cetuximab (347)
osimertinib (301)
erlotinib (235)
afatinib (227)
gefitinib (194)
panitumumab (123)
lapatinib (107)
neratinib (102)
pyrotinib (79)
brigatinib (50)
icotinib (45)
aumolertinib (39)
amivantamab-vmjw (25)
firmonertinib (14)
mobocertinib (12)
lazertinib (12)
BGB-283 (12)
tarloxotinib bromide (7)
WZ4002 (7)
CH7233163 (6)
H002 (6)
nimotuzumab (6)
BLU-945 (6)
ASLAN001 (6)
CL-387785 (5)
GB263T (5)
rociletinib (5)
BDTX-189 (5)
AEE788 (4)
BI-4020 (4)
tomuzotuximab (4)
JIN-A02 (4)
MET306 (4)
EGF816 (4)
BDTX-1535 (4)
AFM24 (3)
BLU-701 (3)
GC-1118A (3)
necitumumab (3)
befotertinib (3)
sunvozertinib (3)
zorifertinib (3)
BCA101 (3)
S95026 (3)
ASP8273 (3)
MCLA-129 (3)
SZMD4 (3)
ACE2016 (2)
BI-732 (2)
BLU-451 (2)
Bay846 (2)
ERAS-801 (2)
OBX02-011 (2)
olmutinib (2)
QL1203 (2)
CLN-081 (2)
14aj (1)
αEGFR (1)
ABP 494 (cetuximab biosimilar) (1)
APL-103 (1)
BPI-15086 (1)
BPI-361175 (1)
Compound 6a (1)
abivertinib (1)
sevabertinib (1)
KKI04 (1)
PH001 (1)
rilertinib (1)
TAS3351 (1)
TRX-221 (1)
WSD0922 (1)
JMT101 (1)
RT1978 (1)
HMPL-813 (1)
SI-B001 (1)
ASK120067 (1)
HLX07 (1)
Hemay022 (1)
KD019 (1)
ABT-101 (0)
AC480 (0)
AG1478 (0)
BBT-207 (0)
BC3448 (0)
BMS690514 (0)
BNA035 (0)
CM93 (0)
CUDC-101 (0)
EGF-PTI (0)
DF9001 (0)
EGFR (0)
STI-001 (cetuximab biosimilar) (0)
FHND9041 (0)
HS-10375 (0)
antroquinonol (0)
zalutumumab (0)
IAE0972 (0)
IBI-334 (0)
JANX008 (0)
JNJ-26483327 (0)
JS111 (0)
asandeutertinib (0)
MM-151 (0)
MP412 (0)
MTX-211 (0)
PF-08046052 (0)
PM1080 (0)
QLH11811 (0)
rindopepimut (0)
SR13668 (0)
SYN004 (0)
Sym013 (0)
TAK-186 (0)
TAK-285 (0)
TAS-121 (0)
TAVO412 (0)
TQ-B3456 (0)
TQB3804 (0)
U3-1565 (0)
Undisclosed EGFR inhibitor (0)
XZP-5809 (0)
simotinib (0)
ZN-e4 (0)
AST1306 (0)
SY101 (0)
Ami-LC (0)
PLB1004 (0)
EMB-01 (0)
cetuximab biosimilar (0)
cipatinib (0)
ABT-806 (0)
MEHD7945A (0)
RO5083945 (0)
TL007 (0)
EMD 72000 (0)
PF-06747775 (0)
JNJ-64041757 (0)
KBP-5209 (0)
SKLB-1028 (0)
AZD8931 (0)
PD173074 (10)
AG-1296 (1)
vorolanib (1)
KC1036 (1)
quercetin (0)
Tyrosine Kinase inhibitors (0)
SU5416 (0)
XL092 (0)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR exon 19 deletion
Non Small Cell Lung Cancer
EGFR exon 19 deletion
Non Small Cell Lung Cancer
BBT-176
Sensitive: C2 – Inclusion Criteria
BBT-176
Sensitive
:
C2
BBT-176
Sensitive: C2 – Inclusion Criteria
BBT-176
Sensitive
:
C2
EGFR C797S
Non Small Cell Lung Cancer
EGFR C797S
Non Small Cell Lung Cancer
BBT-176
Sensitive: C3 – Early Trials
BBT-176
Sensitive
:
C3
BBT-176
Sensitive: C3 – Early Trials
BBT-176
Sensitive
:
C3
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
BBT-176
Sensitive: C3 – Early Trials
BBT-176
Sensitive
:
C3
BBT-176
Sensitive: C3 – Early Trials
BBT-176
Sensitive
:
C3
EGFR C797S + EGFR T790M + EGFR exon 19 deletion
Non Small Cell Lung Cancer
EGFR C797S + EGFR T790M + EGFR exon 19 deletion
Non Small Cell Lung Cancer
BBT-176
Sensitive: C3 – Early Trials
BBT-176
Sensitive
:
C3
BBT-176
Sensitive: C3 – Early Trials
BBT-176
Sensitive
:
C3
EGFR mutation
Non Small Cell Lung Cancer
EGFR mutation
Non Small Cell Lung Cancer
BBT-176
Sensitive: C3 – Early Trials
BBT-176
Sensitive
:
C3
BBT-176
Sensitive: C3 – Early Trials
BBT-176
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.